Trial Profile
Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2010
Price :
$35
*
At a glance
- Drugs Nemonoxacin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 01 Jan 2010 Results reported in Antimicrobial Agents and Chemotherapy.
- 24 Oct 2007 Status change
- 04 Oct 2007 Results have been presented.